Compare OKYO & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OKYO | DMA |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.7M | 77.7M |
| IPO Year | 2022 | N/A |
| Metric | OKYO | DMA |
|---|---|---|
| Price | $1.75 | $8.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 378.8K | 34.6K |
| Earning Date | 07-18-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.03 | $4.78 |
| 52 Week High | $3.35 | $8.00 |
| Indicator | OKYO | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 41.73 |
| Support Level | $1.86 | $8.67 |
| Resistance Level | $2.23 | $8.81 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 18.22 | 30.56 |
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.